Discover our unique tools for
peptide dosage, peptide cycles and peptide stack builder
This section is intended as a reference overview of publicly available research observations, gathered from published studies and experimental reports.
Please note that this information does not constitute medical advice or peptide dosage recommendations. The data presented here reflects experimental contexts only and should not be interpreted as guidance for personal use.
Always remember that peptides discussed in this database may differ in their regulatory status, and many remain investigational compounds studied primarily in research settings.
How to interpret the “Effectiveness” and “Safety” indicators
The Effectiveness and Safety indicators are designed to help readers quickly understand the current level of scientific evidence and potential risk associated with each peptide discussed in this database.
These ratings are not medical recommendations and do not represent official clinical guidelines. Instead, they summarize the current state of publicly available scientific knowledge, including clinical trials, experimental research, and mechanistic understanding of the compound.
Effectiveness
The Effectiveness indicator reflects how strong the scientific evidence is for the biological effects attributed to a given peptide.
The rating is based on:
- regulatory approval status of the substance
- availability of human clinical trial data
- results of preclinical research (animal or cellular studies)
- consistency of reported biological effects with known mechanisms of action
The scale used on this website is:
■■■■■
The peptide is used as an approved pharmaceutical drug or an established medical therapy supported by extensive clinical research.
■■■■
The peptide is currently in advanced clinical trials or late-stage development with promising human data.
■■■
The peptide has been studied experimentally and shows promising biological effects, but clinical evidence remains limited.
■■
The peptide’s effects are theoretically plausible based on known biological mechanisms, but supporting experimental data are limited.
■
There is little convincing evidence that the peptide produces the claimed effects.
Safety
The Safety indicator estimates the relative level of risk associated with the compound based on available scientific knowledge.
The rating takes into account:
- regulatory approval status of the substance
- known adverse effects reported in clinical trials
- biological pathways affected by the peptide
- theoretical risks suggested by experimental research
- absence or presence of long-term human data
The scale used on this website is:
■■■■■
The compound is an approved medicine or established therapy with a well-characterized safety profile when used appropriately.
■■■■
The compound is still experimental but has shown a relatively favorable safety profile in clinical or early clinical studies.
■■■
There is a noticeable level of uncertainty or potential risk based on available data.
■■
The compound may carry significant biological risks or affect pathways associated with serious adverse effects.
■
Very limited safety data are available, and the theoretical risk may be high.
| Peptide | Axis | Main action | Dose | Frequency | Timing | Cycle ON | Cycle OFF | Effectiveness | Safety |
|---|
The table below is for educational purposes only and may be based on unverified sources of information. It should not be considered a treatment planning tool. If you wish to pursue treatment, please consult with a qualified healthcare professional.
Additional tools
The following tools are for educational purposes only and should not be used to plan any therapy. Before making any medical decisions, especially regarding medication, consult a healthcare professional.